REQUEST A DEMO
Total
USD $0.00
Search more companies

Bioadvanced CIA Ltda (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Bioadvanced CIA Ltda Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Bioadvanced CIA Ltda is a company in Ecuador, with a head office in Quito. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. It was established on April 07, 2011. It currently has a total number of 3 (2023) employees. In 2023, the company reported a net sales revenue increase of 5.26%. There was a total growth of 9.68% in Bioadvanced CIA Ltda’s total assets over the same period. The enterprise’s net profit margin increased by 3.27% in 2023.

Headquarters
Calle T Oe11-112
Quito; Pichincha;

Contact Details: Purchase the Bioadvanced CIA Ltda report to view the information.

Website: http://www.bioadvanced.com.ec

Basic Information
Total Employees:
Purchase the Bioadvanced CIA Ltda report to view the information.
Outstanding Shares:
Purchase the Bioadvanced CIA Ltda report to view the information.
Registered Capital:
Purchase the Bioadvanced CIA Ltda report to view the information.
Incorporation Date:
April 07, 2011
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
55%
Purchase this report to view the information.
30%
Purchase this report to view the information.
15%
Company Performance
Financial values in the chart are available after Bioadvanced CIA Ltda report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
5.26%
Total operating revenue
5.26%
Operating profit (EBIT)
49.46%
EBITDA
44.5%
Net Profit (Loss) for the Period
60.46%
Total assets
9.68%
Total equity
24.47%
Operating Profit Margin (ROS)
3.99%
Net Profit Margin
3.27%
Return on Equity (ROE)
4.41%
Debt to Equity Ratio
-0.93%
Quick Ratio
0.16%
Cash Ratio
0.12%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?